Clinical Image

A rare case of abdominal pain and hematuria from retroaortic left renal vein

<h2>Clinical Image</h2> <p>A 62-year-old female with a history of arterial hypertension, attended the emergency department due to pain in the left flank. On physical examination no showed signs of peritoneal irritation. Urinalysis was indicated, that reported microscopic hematur...

Mini Review

Could metabolic risk factors contribute to the development of cervical cancer?

<h2>Abstract</h2> <p>The role of human papillomavirus infection as etiological factor for cervical squamous intraepithelial lesions and cervical cancer is well established. However, the presence of this virus is not sufficient condition for developing of cervical cancer. Current...

Research Article

Theoretical study on binding interactions of laccase-enzyme from Ganoderma weberianum with multiples ligand substrates with environmental impact

<h2>Abstract</h2> <p>Laccase catalyzes oxidation of lignin and aromatic compound with similar structure to this one. Their low substrate specificity results on degradation of similar phenolic compounds. In this context, Molecular Docking was performed with different ligands sugg...

Research Article

Design and validation of an Index to predict the development of Hypertensive Cardiopathy

Introduction: The high morbidity and mortality by hypertensive cardiopathy demand the construction and validation of tools to stratify the risk of developing this condition.

Objective: To design and validate an index, based on risk factors, that per...

Research Article

Non-hemodynamic factors associated to the risk of developing hypertensive cardiopathy

Introduction: Hypertensive cardiopathy is the target organ lesion caused by arterial hypertension (HTN) that exhibits the highest morbidity and mortality rates. Although the importance of hemodynamic overload exerted by HTN on the onset of cardiopathy is well established, seve...

Letter to the Editor

The Daring of Biosimilars

The so-called “biotechnological revolution” is changing the structure of the Pharmacopoeia [1]. The space of biological products, previously limited to blood products and vaccines, grew from the introduction of first recombinant therapeutics in the 1980s until attaining a 25% by va...